Income statement
USD
| Metric | 2005 | 2004 | 2003 | 2002 | 2001 |
|---|---|---|---|---|---|
| Revenue | 410M | 367M | 220M | 123M | 16M |
| Gross Profit | 86M | 85M | 67M | 38M | 7M |
| Operating Income | -4M | -6M | 2M | 4M | -5M |
| EBITDA | 3M | 6M | 7M | 3M | -4M |
| Net Income | -10M | -13M | -786K | 454K | -17M |
| EPS (Diluted) | β | β | β | β | β |
Industrials
Live Price
Offline$0.0001
+0.00% today
1Y Change
+0.00%
Window
Jun 23, 2025 β Jun 8, 2026
Coverage: 241 bars Β· Jun 23, 2025 β Jun 8, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Stonepath Group Inc. (SGRZ) is a Industrials stock with listed on OTC. The stock last traded around $0.00 and up 0.0% across the available one-year price window (Jun 23, 2025 β Jun 8, 2026). Baseline metrics include revenue growth of +11.8%, EPS growth of +33.3%, a dividend yield of 0.0%. What stands out right now is revenue +11.8%, EPS +33.3%, free cash flow +152.4% with operating margin -0.9% and ROIC -5.6%. Valuation is more restrained than many high-expectation growth names at price/sales 0.0. Stock Foundry combines SGRZ price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Industrials peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SGRZ
β
Normalized return
SPY
β
S&P 500
Excess Return
β
Relative to SPY
SGRZ Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
β
Trailing 1Y
Uses the longest available daily history for SGRZ and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$15.6M
-87.3% YoY
FY Net Income
-$17.5M
-3945.6% YoY
Free Cash Flow
-$783.7K
+67.3% YoY
Revenue Growth
+11.8%
EPS Growth
+33.3%
Gross Margin
21.1%
Net Margin
-2.4%
Income statement
USD
| Metric | 2005 | 2004 | 2003 | 2002 | 2001 |
|---|---|---|---|---|---|
| Revenue | 410M | 367M | 220M | 123M | 16M |
| Gross Profit | 86M | 85M | 67M | 38M | 7M |
| Operating Income | -4M | -6M | 2M | 4M | -5M |
| EBITDA | 3M | 6M | 7M | 3M | -4M |
| Net Income | -10M | -13M | -786K | 454K | -17M |
| EPS (Diluted) | β | β | β | β | β |
Balance sheet
USD
| Metric | 2005 | 2004 | 2003 | 2002 | 2001 |
|---|---|---|---|---|---|
| Cash & Equivalents | 5M | 3M | 3M | 2M | 15M |
| Total Assets | 135M | 123M | 96M | 57M | 41M |
| Total Liabilities | 92M | 73M | 29M | 20M | 8M |
| Shareholder Equity | 36M | 45M | 67M | 37M | 33M |
| Total Debt | 22M | 20M | 2M | 0 | 1M |
| Net Debt | 17M | 17M | -1M | -2M | -14M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
503K
+13.8% YoY
Capital Expenditures
281K
+84.5% YoY
Free Cash Flow
784K
+67.3% YoY
Key ratios
Gross Margin
21.1%
Operating Margin
-0.9%
Net Margin
-2.4%
ROE
-23.9%
Debt / Equity
0.59x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.